Long-Term Returns of Carl Icahn's 40 Activist Targets
In this article, we discuss long-term returns of Carl Icahn's 40 activist targets.
Hologic Inc (HOLX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Citadel Investment Group Ken Griffin | 1,236,277 | $100,101,349 | +84% | 0.02% |
| 2. | Millennium Management Israel Englander | 909,413 | $73,635,171 | +616% | 0.03% |
| 3. | AQR Capital Management Cliff Asness | 872,642 | $70,509,474 | -12% | 0.14% |
| 4. | Bridgewater Associates Ray Dalio | 487,812 | $39,498,138 | -11% | 0.24% |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 437,143 | $35,395,467 | 0.06% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $38.43 | 5,200 | Director | 10,297 | 2018-03-14 | Filing | |
| $38.80 | 13,000 | Director | 17,776 | 2018-03-15 | Filing | |
| $37.88 | 6,600 | Director | 6,954 | 2018-02-13 | Filing | |
| $26.39 | 795 | Officer | 795 | 2014-11-20 | Filing | |
| $25.36 | 7,900 | Director | 7,900 | 2014-09-09 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $79.72 | 10,000 | Director | 57,039 | 2023-06-15 | Filing | |
| $83.73 | 2,390 | Officer | 7,212 | 2023-05-05 | Filing | |
| $85.28 | 9,128 | Officer | 14,298 | 2023-02-07 | Filing | |
| $76.40 | 1,649 | Officer | 8,545 | 2022-12-14 | Filing | |
| $76.02 | 12,501 | Officer, Director | 2,313,970 | 2022-11-30 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 28,500,515 | $2,307,686,700 | 0.05% | |
| 2. | 23,849,548 | $1,931,097,944 | 0.05% | |
| 3. | 11,542,769 | $934,618,006 | 0.04% | |
| 4. | 9,604,686 | $777,691,426 | 0.14% | |
| 5. | 5,391,310 | $435,425,890 | 0.05% |
News See All
Hologic, Inc. (NASDAQ:HOLX) Q3 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to the Hologic's Third Quarter Fiscal 2023 Earnings Conference Call. My name is Cynthia, and I am your operator for today's call.
12 Under-the-Radar Stocks That Are on The Move
Valuations in the US equity market appear overstretched in the aftermath of stocks registering one of the best runs in the first six months of the year.
5 Under-the-Radar Stocks Billionaires Are Loading Up On
In this article, we discuss 5 under-the-radar stocks billionaires are loading up on.
Hologic, Inc. (NASDAQ:HOLX) Q2 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to the Hologic Second Quarter Fiscal 2023 Earnings Conference Call. My name is Rachel, and I'm your operator for today's call.
Hologic, Inc. (NASDAQ:HOLX) Q1 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to Hologic's First Quarter Fiscal 2023 Earnings Conference Call. My name is Justin, and I am your operator for today's call. Today's conference is being recorded.
15 Most Undervalued Quality Stocks To Buy According To Hedge Funds
In this article, we discuss 15 most undervalued quality stocks to buy according to hedge funds.
Top 5 Gainers Today
Shares of Arista Networks, Inc. (NYSE:ANET) rose over four percent in the mid-day trading session today.
10 Best Healthcare Stocks to Buy According to Billionaire Larry Robbins
This article discusses the top 10 healthcare stock picks of billionaire Larry Robbins’ hedge fund Glenview Capital Management.
10 Best Undervalued Large-Cap Stocks According to Hedge Funds
In this article, we discuss the 10 best undervalued large-cap stocks according to hedge funds.
Billionaire Hedge Funds
